Glisoxepide
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
![United States Patent (19) [11] Patent Number: 4,696,815 Schepky Et Al](http://data.docslib.org/img/264x/3385c9774a68dcd67e2c6cb97de42da0.webp)
Top View
- Atc Index 2010
- Pan$European$Multi$Database
- Pharmaabkommen A1 E
- Tables S1–S4
- A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
- Characterizing the Interactions of a Series of Sulfonylurea Analogs And
- (12) Patent Application Publication (10) Pub. No.: US 2012/0329780 A1 Thormann Et Al
- Customs Tariff - Schedule Xxi - 1
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- Tepzz 99 876A T
- WO 2016/034710 Al 10 March 2016 (10.03.2016) P O P C T
- To Decrease Postoperative Complications After Major Abdominal Surgery - a Phase Iia Trial
- Promise of the NLRP3 Inflammasome Inhibitors in in Vivo Disease Models
- [3H]Glibenclamide-Binding Protein, a Putative Neuronal
- ICD-10-CM Table of Drugs 2019
- Online-Only Supplemental Material
- Search Strategy: 1 ((Sick Day$ Or Well Day$) Adj2 (Management Or Protocol$ Or Recommendation$ Or Rule$)).Ti,Ab
- (12) United States Patent (10) Patent No.: US 8,017,633 B2 Kley Et Al